Endothelin receptors, renal effects and blood pressure

Current Opinion in Pharmacology

Volumn 21, Issue , 2015, Pages 25-34

  Boesen, Erika I ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BOSENTAN; DAGLUTRIL; DARUSENTAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR; ENDOTHELIN CONVERTING ENZYME INHIBITOR; ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST; SITAXSENTAN;

ARTICLE; BLOOD PRESSURE; CHRONIC KIDNEY DISEASE; CIRCADIAN RHYTHM; DIABETIC NEPHROPATHY; DISEASE COURSE; DIURESIS; DOSE RESPONSE; DRUG EFFECT; DRUG TARGETING; FLUID RETENTION; GLOMERULUS; HUMAN; HYPERTENSION; KIDNEY DISEASE; KIDNEY INJURY; KIDNEY TUBULE FUNCTION; LIVER TOXICITY; NATRIURESIS; NONHUMAN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RENOVASCULAR DISEASE; RESISTANT HYPERTENSION; SALT INTAKE; SEX DIFFERENCE; SIDE EFFECT; ANIMAL; KIDNEY; KIDNEY DISEASES; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; BLOOD PRESSURE; DIURESIS; ENDOTHELIN RECEPTOR ANTAGONISTS; ENDOTHELIN-1; HUMANS; HYPERTENSION; KIDNEY; KIDNEY DISEASES; RECEPTORS, ENDOTHELIN;

EID: 84919717887     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2014.12.007     Document Type: Review

References (100)

1. M. Yanagisawa, H. Kurihara, S. Kimura, Y. Tomobe, M. Kobayashi, Y. Mitsui, Y. Yazaki, K. Goto, and T. Masaki A novel potent vasoconstrictor peptide produced by vascular endothelial cells Nature 332 1988 411 415
2. D.E. Kohan Endothelin synthesis by rabbit renal tubule cells Am J Physiol 261 1991 F221 F226
3. O.F. Wagner, G. Christ, J. Wojta, H. Vierhapper, S. Parzer, P.J. Nowotny, B. Schneider, W. Waldhausl, and B.R. Binder Polar secretion of endothelin-1 by cultured endothelial cells J Biol Chem 267 1992 16066 16068
4. D.E. Kohan, N.F. Rossi, E.W. Inscho, and D.M. Pollock Regulation of blood pressure and salt homeostasis by endothelin Physiol Rev 91 2011 1 77
5. Y. Rautureau, and E.L. Schiffrin Endothelin in hypertension: an update Curr Opin Nephrol Hypertens 21 2012 128 136
6. B receptors in rats Biochem Biophys Res Commun 199 1994 1461 1465
7. J. Pernow, A. Franco-Cereceda, R. Matran, and J.M. Lundberg Effect of endothelin-1 on regional vascular resistances in the pig J Cardiovasc Pharmacol 13 1989 S205 S206
8. K. Takeya, X. Wang, I. Kathol, K. Loutzenhiser, R. Loutzenhiser, and M.P. Walsh Endothelin-1, but not angiotensin II, induces afferent arteriolar myosin diphosphorylation as a potential contributor to prolonged vasoconstriction Kidney Int 2014 10.1038/ki.2014.284
9. M.J. Meens, N.J. Mattheij, J. Nelissen, P. Lemkens, M.G. Compeer, B.J. Janssen, and J.G. De Mey Calcitonin gene-related peptide terminates long-lasting vasopressor responses to endothelin 1 in vivo Hypertension 58 2011 99 106
10. S. Brodsky, Z. Abassi, J. Wessale, R. Ramadan, J. Winaver, and A. Hoffman Effects of A-192621.1, a specific endothelin-B antagonist, on intrarenal hemodynamic responses to endothelin-1 J Cardiovasc Pharmacol 36 2000 S311 S313
11. R.G. Evans, A.C. Madden, J.J. Oliver, and T.V. Lewis Effects of ET(A)- and ET(B)-receptor antagonists on regional kidney blood flow, and responses to intravenous endothelin-1, in anaesthetized rabbits J Hypertens 19 2001 1789 1799
12. A.W. Cowley Jr. Role of the renal medulla in volume and arterial pressure regulation Am J Physiol 273 1997 R1 R15
13. M.P. Schneider, Y. Ge, D.M. Pollock, J.S. Pollock, and D.E. Kohan Collecting duct-derived endothelin regulates arterial pressure and Na excretion via nitric oxide Hypertension 51 2008 1605 1610
14. D. Nakano, and D.M. Pollock Contribution of endothelin A receptors in endothelin 1-dependent natriuresis in female rats Hypertension 53 2009 324 330
15. M.A. Saleh, E.I. Boesen, J.S. Pollock, V.J. Savin, and D.M. Pollock Endothelin-1 increases glomerular permeability and inflammation independent of blood pressure in the rat Hypertension 56 2010 942 949
16. M.A. Saleh, R.M. Sandoval, G.J. Rhodes, S.B. Campos-Bilderback, B.A. Molitoris, and D.M. Pollock Chronic endothelin-1 infusion elevates glomerular sieving coefficient and proximal tubular albumin reuptake in the rat Life Sci 91 2012 634 637
17. J.B. Heimlich, J.S. Speed, C.J. Bloom, P.M. O'Connor, J.S. Pollock, and D.M. Pollock ET-1 increases reactive oxygen species following hypoxia and high-salt diet in the mouse glomerulus Acta Physiol (Oxf) 2014 10.1111/apha.12397
18. S. Buelli, L. Rosano, E. Gagliardini, D. Corna, L. Longaretti, A. Pezzotta, L. Perico, S. Conti, P. Rizzo, R. Novelli, and M. Morigi Beta-arrestin-1 drives endothelin-1-mediated podocyte activation and sustains renal injury J Am Soc Nephrol 25 2014 523 533
19. O. Lenoir, M. Milon, A. Virsolvy, C. Henique, A. Schmitt, J.M. Masse, Y. Kotelevtsev, M. Yanagisawa, D.J. Webb, S. Richard, and P.L. Tharaux Direct action of endothelin-1 on podocytes promotes diabetic glomerulosclerosis J Am Soc Nephrol 25 2014 1050 1062
20. S. Kelsen, J.E. Hall, and A.R. Chade Endothelin-A receptor blockade slows the progression of renal injury in experimental renovascular disease Am J Physiol Renal Physiol 301 2011 F218 F225
21. A.R. Chade, N.J. Stewart, and P.R. Peavy Disparate effects of single endothelin-A and -B receptor blocker therapy on the progression of renal injury in advanced renovascular disease Kidney Int 85 2014 833 844
22. A.R. Chade, N. Tullos, N.J. Stewart, and B. Surles Endothelin-A receptor antagonism after renal angioplasty enhances renal recovery in renovascular disease J Am Soc Nephrol 2014 10.1681/asn.2014040323
23. R.A. Zager, A.C. Johnson, D. Andress, and K. Becker Progressive endothelin-1 gene activation initiates chronic/end-stage renal disease following experimental ischemic/reperfusion injury Kidney Int 84 2013 703 712
24. D. Ahn, Y. Ge, P.K. Stricklett, P. Gill, D. Taylor, A.K. Hughes, M. Yanagisawa, L. Miller, R.D. Nelson, and D.E. Kohan Collecting duct-specific knockout of endothelin-1 causes hypertension and sodium retention J Clin Invest 114 2004 504 511
25. Y. Ge, A. Bagnall, P.K. Stricklett, K. Strait, D.J. Webb, Y. Kotelevtsev, and D.E. Kohan Collecting duct-specific knockout of the endothelin B receptor causes hypertension and sodium retention Am J Physiol Renal Physiol 291 2006 F1274 F1280
26. D.E. Kohan Role of collecting duct endothelin in control of renal function and blood pressure Am J Physiol Regul Integr Comp Physiol 305 2013 R659 R668
27. M. Herrera, and J.L. Garvin Endothelin stimulates endothelial nitric oxide synthase expression in the thick ascending limb Am J Physiol Renal Physiol 287 2004 F231 F235
28. M. Herrera, and J.L. Garvin A high-salt diet stimulates thick ascending limb eNOS expression by raising medullary osmolality and increasing release of endothelin-1 Am J Physiol Renal Physiol 288 2005 F58 F64
29. M. Herrera, N.J. Hong, P.A. Ortiz, and J.L. Garvin Endothelin-1 inhibits thick ascending limb transport via AKT-stimulated nitric oxide production J Biol Chem 284 2009 1454 1460
30. J.G. Dickhout, T. Mori, and A.W. Cowley Jr. Tubulovascular nitric oxide crosstalk: buffering of angiotensin II-induced medullary vasoconstriction Circ Res 91 2002 487 493
31. A. Hoffman, E. Grossman, D.S. Goldstein, J.R. Gill Jr., and H.R. Keiser Urinary excretion rate of endothelin-1 in patients with essential hypertension and salt sensitivity Kidney Int 45 1994 556 560
32. R.W. Jackson, F.A. Treiber, G.A. Harshfield, J.L. Waller, J.S. Pollock, and D.M. Pollock Urinary excretion of vasoactive factors are correlated to sodium excretion Am J Hypertens 14 2001 1003 1006
33. E.I. Boesen, and D.M. Pollock Acute increases of renal medullary osmolality stimulate endothelin release from the kidney Am J Physiol Renal Physiol 292 2007 F185 F191
34. I. Migas, A. Backer, H. Meyer-Lehnert, and H.J. Kramer Endothelin synthesis by porcine inner medullary collecting duct cells. Effects of hormonal and osmotic stimuli Am J Hypertens 8 1995 748 752
35. T. Yang, Y. Terada, H. Nonoguchi, K. Ujiie, K. Tomita, and F. Marumo Effect of hyperosmolality on production and mRNA expression of ET-1 in inner medullary collecting duct Am J Physiol 264 1993 F684 F689
36. B. Lyon-Roberts, K.A. Strait, E. van Peursem, W. Kittikulsuth, J.S. Pollock, D.M. Pollock, and D.E. Kohan Flow regulation of collecting duct endothelin-1 production Am J Physiol Renal Physiol 300 2011 F650 F656
37. M.M. Pandit, K.A. Strait, T. Matsuda, and D.E. Kohan Na delivery and ENaC mediate flow regulation of collecting duct endothelin-1 production Am J Physiol Renal Physiol 302 2012 F1325 F1330
38. M.P. Schneider, E.W. Inscho, and D.M. Pollock Attenuated vasoconstrictor responses to endothelin in afferent arterioles during a high-salt diet Am J Physiol Renal Physiol 292 2007 F1208 F1214
39. B receptors in the renal medulla Hypertension 41 2003 1359 1363
40. I.J. Lynch, A.K. Welch, D.E. Kohan, B.D. Cain, and C.S. Wingo Endothelin-1 inhibits sodium reabsorption by ET(A) and ET(B) receptors in the mouse cortical collecting duct Am J Physiol Renal Physiol 305 2013 F568 F573
41. D. Stuart, S. Rees, S.K. Woodward, R. Koesters, K.A. Strait, and D.E. Kohan Disruption of the endothelin A receptor in the nephron causes mild fluid volume expansion BMC Nephrol 13 2012 166
42. D. Stuart, M. Chapman, S. Rees, S. Woodward, and D.E. Kohan Myocardial, smooth muscle, nephron, and collecting duct gene targeting reveals the organ sites of endothelin A receptor antagonist fluid retention J Pharmacol Exp Ther 346 2013 182 189
43. 2+ signaling in the IMCD Am J Physiol Renal Physiol 305 2013 F1099 F1104
44. Y. Ge, P.K. Stricklett, A.K. Hughes, M. Yanagisawa, and D.E. Kohan Collecting duct-specific knockout of the endothelin a receptor alters renal vasopressin responsiveness, but not sodium excretion or blood pressure Am J Physiol Renal Physiol 289 2005 F692 F698
45. Y. Ge, A. Bagnall, P.K. Stricklett, D. Webb, Y. Kotelevtsev, and D.E. Kohan Combined knockout of collecting duct endothelin A and B receptors causes hypertension and sodium retention Am J Physiol Renal Physiol 295 2008 F1635 F1640
46. B receptor heterodimers in isolated rat mesenteric resistance arteries Life Sci 111 2014 36 41
47. J. Richards, A.K. Welch, S.J. Barilovits, S. All, K.Y. Cheng, C.S. Wingo, B.D. Cain, and M.L. Gumz Tissue-specific and time-dependent regulation of the endothelin axis by the circadian clock protein Per1 Life Sci 2014 10.1016/j.lfs.2014.03.028
48. L.R. Stow, J. Richards, K.Y. Cheng, I.J. Lynch, L.A. Jeffers, M.M. Greenlee, B.D. Cain, C.S. Wingo, and M.L. Gumz The circadian protein period 1 contributes to blood pressure control and coordinately regulates renal sodium transport genes Hypertension 59 2012 1151 1156
49. N. Dhaun, R. Moorhouse, I.M. MacIntyre, V. Melville, W. Oosthuyzen, R.A. Kimmitt, K.E. Brown, E.D. Kennedy, J. Goddard, and D.J. Webb Diurnal variation in blood pressure and arterial stiffness in chronic kidney disease: the role of endothelin-1 Hypertension 64 2014 296 304
50. G.L. Bakris, L.H. Lindholm, H.R. Black, H. Krum, S. Linas, J.V. Linseman, S. Arterburn, P. Sager, and M. Weber Divergent results using clinic and ambulatory blood pressures: report of a darusentan-resistant hypertension trial Hypertension 56 2010 824 830
51. H. Krum, R.J. Viskoper, Y. Lacourciere, M. Budde, and V. Charlon The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension Bosentan hypertension investigators N Engl J Med 338 1998 784 790
52. R. Nakov, E. Pfarr, S. Eberle, and H. Investigators Darusentan: an effective endothelin A receptor antagonist for treatment of hypertension Am J Hypertens 15 2002 583 589
53. M.A. Weber, H. Black, G. Bakris, H. Krum, S. Linas, R. Weiss, J.V. Linseman, B.L. Wiens, M.S. Warren, and L.H. Lindholm A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial Lancet 374 2009 1423 1431
54. B.T. Alexander, K.L. Cockrell, A.N. Rinewalt, J.N. Herrington, and J.P. Granger Enhanced renal expression of preproendothelin mRNA during chronic angiotensin II hypertension Am J Physiol Regul Integr Comp Physiol 280 2001 R1388 R1392
55. A activation mediates angiotensin II-induced infiltration of renal cortical T cells J Am Soc Nephrol 22 2011 2187 2192
56. B receptor antagonists in hypertension induced by angiotensin II and high-salt diet Can J Physiol Pharmacol 88 2010 802 807
57. M. Barton, L.V. d'Uscio, S. Shaw, P. Meyer, P. Moreau, and T.F. Luscher ET(A) receptor blockade prevents increased tissue endothelin-1, vascular hypertrophy, and endothelial dysfunction in salt-sensitive hypertension Hypertension 31 1998 499 504
58. A receptor blockade attenuates the hypertension but not renal dysfunction in doca-salt rats Am J Physiol 275 1998 R245 R252
59. Y. Matsumura, N. Hashimoto, S. Taira, T. Kuro, R. Kitano, M. Ohkita, T.J. Opgenorth, and M. Takaoka Different contributions of endothelin-A and endothelin-B receptors in the pathogenesis of deoxycorticosterone acetate-salt-induced hypertension in rats Hypertension 33 1999 759 765
60. A.C. Montezano, G.E. Callera, A.L. Mota, Z.B. Fortes, D. Nigro, M.H. Carvalho, T.M. Zorn, and R.C. Tostes Endothelin-1 contributes to the sexual differences in renal damage in DOCA-salt rats Peptides 26 2005 1454 1462
61. B.T. Alexander, A.N. Rinewalt, K.L. Cockrell, M.B. Massey, W.A. Bennett, and J.P. Granger Endothelin type A receptor blockade attenuates the hypertension in response to chronic reductions in uterine perfusion pressure Hypertension 37 2001 485 489
62. T. Nakamura, I. Ebihara, Y. Tomino, and H. Koide Effect of a specific endothelin A receptor antagonist on murine lupus nephritis Kidney Int 47 1995 481 489
63. Y.Y. Kisanuki, N. Emoto, T. Ohuchi, B. Widyantoro, K. Yagi, K. Nakayama, R.M. Kedzierski, R.E. Hammer, H. Yanagisawa, S.C. Williams, and J.A. Richardson Low blood pressure in endothelial cell-specific endothelin 1 knockout mice Hypertension 56 2010 121 128
64. F. Amiri, P. Paradis, T.L. Reudelhuber, and E.L. Schiffrin Vascular inflammation in absence of blood pressure elevation in transgenic murine model overexpressing endothelin-1 in endothelial cells J Hypertens 26 2008 1102 1109
65. F. Amiri, E.A. Ko, D. Javeshghani, T.L. Reudelhuber, and E.L. Schiffrin Deleterious combined effects of salt-loading and endothelial cell restricted endothelin-1 overexpression on blood pressure and vascular function in mice J Hypertens 28 2010 1243 1251
66. T. Nakamura, I. Ebihara, M. Fukui, S. Osada, Y. Tomino, T. Masaki, K. Goto, Y. Furuichi, and H. Koide Renal expression of mRNAs for endothelin-1, endothelin-3 and endothelin receptors in NZB/W F1 mice Renal Physiol Biochem 16 1993 233 243
67. J.M. Sasser, J.S. Pollock, and D.M. Pollock Renal endothelin in chronic angiotensin II hypertension Am J Physiol Regul Integr Comp Physiol 283 2002 R243 R248
68. N. Dhaun, P. Lilitkarntakul, I.M. Macintyre, E. Muilwijk, N.R. Johnston, D.C. Kluth, D.J. Webb, and J. Goddard Urinary endothelin-1 in chronic kidney disease and as a marker of disease activity in lupus nephritis Am J Physiol Renal Physiol 296 2009 F1477 F1483
69. W.H. Herman, S.N. Emancipator, R.L. Rhoten, and M.S. Simonson Vascular and glomerular expression of endothelin-1 in normal human kidney Am J Physiol Renal Physiol 275 1998 F8 F17
70. J. Goddard, N.R. Johnston, M.F. Hand, A.D. Cumming, T.J. Rabelink, A.J. Rankin, and D.J. Webb Endothelin-A receptor antagonism reduces blood pressure and increases renal blood flow in hypertensive patients with chronic renal failure: a comparison of selective and combined endothelin receptor blockade Circulation 109 2004 1186 1193
71. M.H. Sedeek, M.T. Llinas, H. Drummond, L. Fortepiani, S.R. Abram, B.T. Alexander, J.F. Reckelhoff, and J.P. Granger Role of reactive oxygen species in endothelin-induced hypertension Hypertension 42 2003 806 810
72. K. Tanaka, K. Yoshioka, K. Tatsumi, S. Kimura, and Y. Kasuya Endothelin regulates function of IL-17-producing T cell subset Life Sci 2014 10.1016/j.lfs.2014.01.084
73. M.S. Madhur, H.E. Lob, L.A. McCann, Y. Iwakura, Y. Blinder, T.J. Guzik, and D.G. Harrison Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction Hypertension 55 2010 500 507
74. C. De Miguel, and J.S. Pollock Does endoplasmic reticulum stress mediate endothelin-1-induced renal inflammation Am J Physiol Regul Integr Comp Physiol 305 2013 R107 R109
75. W. Kittikulsuth, J.S. Pollock, and D.M. Pollock Sex differences in renal medullary endothelin receptor function in angiotensin II hypertensive rats Hypertension 58 2011 212 218
76. V.D. Ramseyer, and J. Garvin Endothelin-1-induced inhibition of NKCC2 activity is blunted in thick ascending limbs from angiotensin II-hypertensive rats FASEB J 26 2012 688.6
77. W. Kittikulsuth, J.S. Pollock, and D.M. Pollock Loss of renal medullary endothelin B receptor function during salt deprivation is regulated by angiotensin II Am J Physiol Renal Physiol 303 2012 F659 F666
78. J.S. Speed, B. LaMarca, H. Berry, K. Cockrell, E.M. George, and J.P. Granger Renal medullary endothelin-1 is decreased in dahl salt-sensitive rats Am J Physiol Regul Integr Comp Physiol 301 2011 R519 R523
79. M. Kakoki, Y. Hirata, H. Hayakawa, A. Tojo, D. Nagata, E. Suzuki, K. Kimura, A. Goto, K. Kikuchi, T. Nagano, and M. Omata Effects of hypertension, diabetes mellitus, and hypercholesterolemia on endothelin type B receptor-mediated nitric oxide release from rat kidney Circulation 99 1999 1242 1248
80. D.M. Pollock, G.H. Allcock, A. Krishnan, B.D. Dayton, and J.S. Pollock Upregulation of endothelin B receptors in kidneys of DOCA-salt hypertensive rats Am J Physiol Renal Physiol 278 2000 F279 F286
81. G.H. Allcock, M. Hukkanen, J.M. Polak, J.S. Pollock, and D.M. Pollock Increased nitric oxide synthase-3 expression in kidneys of deoxycorticosterone acetate-salt hypertensive rats J Am Soc Nephrol 10 1999 2283 2289
82. E.I. Boesen, W.P. Anderson, and M.M. Kett Role of endothelin in noradrenaline-induced hypertension in rats J Hypertens 23 2005 987 993
83. M. Li, X. Dai, S. Watts, D. Kreulen, and G. Fink Increased superoxide levels in ganglia and sympathoexcitation are involved in sarafotoxin 6c-induced hypertension Am J Physiol Regul Integr Comp Physiol 295 2008 R1546 R1554
84. G. Fink, M. Li, Y. Lau, J. Osborn, and S. Watts Chronic activation of endothelin B receptors: new model of experimental hypertension Hypertension 50 2007 512 518
85. D. de Zeeuw, B. Coll, D. Andress, J.J. Brennan, H. Tang, M. Houser, R. Correa-Rotter, D. Kohan, H.J. Lambers Heerspink, H. Makino, and V. Perkovic The endothelin antagonist atrasentan lowers residual albuminuria in patients with type 2 diabetic nephropathy J Am Soc Nephrol 25 2014 1083 1093
86. A. Parvanova, I.M. van der Meer, I. Iliev, A. Perna, F. Gaspari, R. Trevisan, A. Bossi, G. Remuzzi, A. Benigni, P. Ruggenenti Daglutril in Diabetic Nephropathy Study G Effect on blood pressure of combined inhibition of endothelin-converting enzyme and neutral endopeptidase with daglutril in patients with type 2 diabetes who have albuminuria: a randomised, crossover, double-blind, placebo-controlled trial Lancet Diabetes Endocrinol 1 2013 19 27
87. M.M. Hoeper Liver toxicity: the achilles' heel of endothelin receptor antagonist therapy Eur Respir J 34 2009 529 530
88. D.E. Kohan, J.G. Cleland, L.J. Rubin, D. Theodorescu, and M. Barton Clinical trials with endothelin receptor antagonists: what went wrong and where can we improve Life Sci 91 2012 528 539
89. P. Muntner, B.R. Davis, W.C. Cushman, S. Bangalore, D.A. Calhoun, S.L. Pressel, H.R. Black, J.B. Kostis, J.L. Probstfield, P.K. Whelton, and M. Rahman Treatment-resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT) Hypertension 64 2014 1012 1021
90. E. Belaidi, M. Joyeux-Faure, C. Ribuot, S.H. Launois, P. Levy, and D. Godin-Ribuot Major role for hypoxia inducible factor-1 and the endothelin system in promoting myocardial infarction and hypertension in an animal model of obstructive sleep apnea J Am Coll Cardiol 53 2009 1309 1317
91. M.H. Weinberger Salt sensitivity of blood pressure in humans Hypertension 27 1996 481 490
92. S. Ergul, D.C. Parish, D. Puett, and A. Ergul Racial differences in plasma endothelin-1 concentrations in individuals with essential hypertension Hypertension 28 1996 652 655
93. F.A. Treiber, R.W. Jackson, H. Davis, J.S. Pollock, G. Kapuku, G.A. Mensah, and D.M. Pollock Racial differences in endothelin-1 at rest and in response to acute stress in adolescent males Hypertension 35 2000 722 725
94. N. Dhaun, I.M. MacIntyre, D. Kerr, V. Melville, N.R. Johnston, S. Haughie, J. Goddard, and D.J. Webb Selective endothelin-A receptor antagonism reduces proteinuria, blood pressure, and arterial stiffness in chronic proteinuric kidney disease Hypertension 57 2011 772 779
95. N. Dhaun, I.M. Macintyre, V. Melville, P. Lilitkarntakul, N.R. Johnston, J. Goddard, and D.J. Webb Blood pressure-independent reduction in proteinuria and arterial stiffness after acute endothelin-A receptor antagonism in chronic kidney disease Hypertension 54 2009 113 119
96. R.R. Wenzel, T. Littke, S. Kuranoff, C. Jurgens, H. Bruck, E. Ritz, T. Philipp, and A. Mitchell Avosentan reduces albumin excretion in diabetics with macroalbuminuria J Am Soc Nephrol 20 2009 655 664
97. J.F. Mann, D. Green, K. Jamerson, L.M. Ruilope, S.J. Kuranoff, T. Littke, and G. Viberti Avosentan for overt diabetic nephropathy J Am Soc Nephrol 21 2010 527 535
98. D.E. Kohan, Y. Pritchett, M. Molitch, S. Wen, T. Garimella, P. Audhya, and D.L. Andress Addition of atrasentan to renin-angiotensin system blockade reduces albuminuria in diabetic nephropathy J Am Soc Nephrol 22 2011 763 772
99. D.L. Andress, B. Coll, Y. Pritchett, J. Brennan, M. Molitch, and D.E. Kohan Clinical efficacy of the selective endothelin A receptor antagonist, atrasentan, in patients with diabetes and chronic kidney disease (CKD) Life Sci 91 2012 739 742
100. H. Penn, N. Quillinan, K. Khan, K. Chakravarty, V.H. Ong, A. Burns, and C.P. Denton Targeting the endothelin axis in scleroderma renal crisis: rationale and feasibility QJM 106 2013 839 848